Outlook Therapeutics, Inc.
NASDAQ:OTLKBiotechnology
Healthcare
$0.40 -5.76%
-$0.10 today
- Market cap
- $97.62M
- Beta
- 0.98
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$0.74
52W Low $0.16High $3.39
Volume 6.81M
Average 17.46M
Balance Sheet
Inspect the capital base behind the business.
Assets
$18.58M
FY 2025 · Annual
-35.5% YoYLiabilities
$50.77M
FY 2025 · Annual
-50.2% YoYEquity
-$32.19M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY 2021 Sep 2021 | FY 2022 Sep 2022 | FY 2023 Sep 2023 | FY 2024 Sep 2024 | FY 2025 Sep 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 14.48M | 17.4M | 23.39M | 14.93M | 8.08M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 1.49M |
| Inventory | 0 | 0 | 0 | 0 | 3.34M |
| Other Current Assets | 324 | 0 | 7.59M | 12.49M | 4.48M |
| Total Current Assets | 21.51M | 27.52M | 30.98M | 27.42M | 17.39M |
| Property, Plant & Equipment (Net) | 275.05K | 70.36K | 26.17K | 274.65K | 225.51K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 853.66K | 804.93K | 793.93K | 693.19K | 552.18K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 174.59K | 132.02K | 501.3K | 439.28K | 417.52K |
| Total Non-current Assets | 1.3M | 1.01M | 1.32M | 1.41M | 1.2M |
| Total Assets | 22.81M | 28.53M | 32.3M | 28.82M | 18.58M |
| Account Payables | 2.2M | 3.49M | 6.57M | 7.97M | 10.19M |
| Short-term Debt | 904.2K | 10.92M | 35.55M | 29.44M | 29.95M |
| Tax Payables | 1.86M | 1.86M | 1.86M | 1.86M | 302B |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | (217) | 1.45M | 1.83M | 1.01M | 3.03M |
| Total Current Liabilities | 6.75M | 19.73M | 46.73M | 42.55M | 45.81M |
| Long-term Debt | 10.89M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 522.92K | 57.14K | 6.22K | 59.1M | 4.77M |
| Total Non-current Liabilities | 11.45M | 61.41K | 6.22K | 59.35M | 4.96M |
| Total Liabilities | 18.2M | 19.79M | 46.74M | 101.9M | 50.77M |
| Common Stock | 1.76M | 2.27M | 2.6M | 239.06K | 538.87K |
| Retained Earnings | (342.88M) | (408.94M) | (467.92M) | (543.28M) | (605.71M) |
| Accumulated OCI | (22.81T) | 417.67M | (32.3T) | 0 | 0 |
| Other Stockholders Equity | (167) | (28.53T) | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 4.61M | 8.74M | (14.44M) | (73.08M) | (32.19M) |
| Total Debt | 11.9M | 10.96M | 35.56M | 29.74M | 30.19M |
| Net Debt | (2.57M) | (6.44M) | 12.16M | 14.81M | 22.11M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $7.7M |
| Receivables | $2.7M |
| Inventory | $3.3T |
| Other Current | -$3.3T |
| Total Current Assets | $20.9M |
| PP&E (Net) | $199.0K |
| Long-term Investments | $468.4K |
| Other Non-current | $320.3K |
| Total Non-current Assets | $987.7K |
| Total Assets | $21.9M |
Analysis
Selected assets total $21.9M for Latest. The largest visible component is Inventory at $3.3T, about 15275808.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Oct 13, 2026 | |
| 8-K | Current report | Sep 30, 2026 | |
| 8-K | Current report | Sep 18, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 2, 2026 | |
| 3 | Initial statement of beneficial ownership | Sep 2, 2026 |
How much cash does OTLK have?
Outlook Therapeutics, Inc. (OTLK) reported $8.08M in cash and equivalents in fiscal 2025.
How much debt does OTLK carry?
Outlook Therapeutics, Inc. (OTLK) reported $30.19M of total debt, with net debt of $22.11M.
Continue the stock analysis
Jump to another research area for this company.